Press Room

April 30, 2010

New Data from Phase III Lung Cancer Trial Show VeriStrat® Identifies Patients Likely to Respond to Erlotinib

April 19, 2010

Biodesix Announces VeriStrat® Outcomes Data in Lung Cancer to be Presented at IASLC/ESMO 2nd European Lung Cancer Conference

May 14, 2009

Biodesix Announces VeriStrat® Data in Head and Neck Cancer to be Presented at ASCO

May 5, 2009

Biodesix Advances the Field of Personalized Medicine with the Launch of VeriStrat®

Events

13th World Conference on Lung Cancer

Attend Our Symposium and Visit Our Booth at the 13th World Conference on Lung Cancer.  July 31 – August 4, 2009.  San Francisco, California

ASCO

Join Us for ASCO!  45th Annual Meeting of the American Society of Clinical Oncology.  May 29 – June 2, 2009. Orlando, Florida